Navigation Links
PharMEDium Applauds Passage of Legislation to Strengthen Oversight of the Compounding Industry
Date:11/18/2013

WASHINGTON, Nov. 18, 2013 /PRNewswire/ -- PharMEDium congratulates Congress for coming together in a bipartisan fashion to reform the existing patchwork of compounding regulations. One year after the most deadly drug contamination incident in U.S. history, the Senate approved by voice vote the House-passed legislation to overhaul the way compounding is regulated. This process began many months ago and PharMEDium would like to applaud the determination and leadership of the Members of the Senate H.E.L.P. Committee and the House Energy and Commerce committee and their dedicated staffs in strengthening the oversight of the compounding industry.

The Drug Quality and Security Act will finally instill clarity and certainty into the oversight of compounding facilities, ensuring that large-scale sterile compounding operations that conduct interstate commerce are subject to appropriate federal oversight. This will result in a significant advance in the integrity of customized, compounded sterile preparations administered to millions of patients.

PharMEDium, the nation's leading provider of sterile admixture preparations for hospitals across the country, supports the establishment of a new category for "outsourcing facilities" that are registered with the U.S. Food and Drug Administration (FDA), are held to rigorous manufacturing-like standards, and are subject to routine FDA inspections. Although PharMEDium would have preferred mandatory FDA registration for large-scale sterile compounding operations that ship across state lines, we believe that effective communication between state and federal authorities will have the same effect.

PharMEDium has long advocated for clearer FDA authority and stronger oversight and we look forward to working with the Agency and other policymakers as they implement this landmark legislation. We believe that if implemented swiftly and fully, the Drug Quality and Security Act will help prevent another national disaster like last year's devastating fungal meningitis outbreak.

Who we are: PharMEDium is the nation's leading provider of hospital pharmacy-outsourced, sterile admixture services with centers in four states and thousands of acute care hospital customers nationwide. Our qualified personnel and state-of-the-art centers are registered with the FDA, licensed by the states, and governed by our own rigorous quality standards. We begin the compounding process with sterile FDA-approved finished drugs from FDA-approved drug manufacturers. It is our mission to be the preeminent provider of choice for hospital customers and to attain the highest degree of integrity in the compounding of sterile preparations.


'/>"/>
SOURCE PharMEDium
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PharMEDium Highlights Enhanced Labeling for ICU Services at Critical Care Expo
2. PharMEDium Encourages Swift Action to Strengthen Federal Oversight of Advanced Sterile Compounding
3. PharMEDium Supports Draft Legislation, Efforts to Strengthen Oversight of the Compounding Industry
4. CHPA Applauds Alabama Senates Passage of Anti-Meth Bill
5. CHPA Applauds Alabamas Adoption Of HB 363
6. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
7. CHPA Applauds Arizonas Adoption Of HB 2263
8. Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories
9. Obesity Care Continuum (OCC) Applauds FDA for Approval of New Obesity Drug
10. Novation Applauds FDAs Unique Device Identification Rule
11. American Academy of Pain Medicine Applauds FDA Action to Enhance Patient Safety on Prescribing Opioids; Offers AAPM Safe Opioid Prescribing Course as Educational Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... Feb. 9, 2016 On Tuesday, ... (FDA) met with its Arthritis Advisory Committee ... of Johnson & Johnson,s Remicade and most ... in the U.S. The Biologics Prescribers Collaborative ... - Alliance for Patient Access, American Association ...
(Date:2/10/2016)... 2016 Demonstrates changes in ... receptor selectivity   1 receptor ... entered clinical development as a new treatment for ...   --> 1 receptor agonist, ... clinical development as a new treatment for cognitive ...
(Date:2/9/2016)... Corporation (NASDAQ: PODD ) (Insulet or the Company), the ... OmniPod ® Insulin Management System, today announced ... Insulet,s Board of Directors. With his appointment, the Board is ... --> --> Mr. Lemoine ... a deep knowledge of accounting, financial reporting and internal controls ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... 2016 , ... The Wickman Agency in Garland, TX has ... community. Pledging to select a new beneficiary every 60 days, the agency will ... is to bring community awareness to important local causes by forming campaigns which ...
(Date:2/10/2016)... ... February 10, 2016 , ... Dr. Peyman Ghasri, skin ... a variety of comprehensive procedures for facial enhancement. The treatments now available at ... enhancement and nasal reshaping. , As a result, patients can improve virtually ...
(Date:2/10/2016)... ... February 10, 2016 , ... Intalere’s ... together more than 200 of the country’s top healthcare executives to share insights ... true benefit of the Forum is the provider-centric perspective, experience, expertise and strategy ...
(Date:2/10/2016)... ... ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral ... December 31, 2015 on Monday, February 29, 2016 after the market closes. , The ... release at 4:30 PM ET. Investors interested in participating by phone are invited to ...
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric therapists ... their patients. Research shows that the Goal Attainment Scale (GAS) captures 20% more ... challenge and learn more about the Goal Attainment Scale, Education Resources Inc. is ...
Breaking Medicine News(10 mins):